What is the prevalence of Cornelia de Lange Syndrome?

Cornelia de Lange syndrome (CdLS) is estimated to affect approximately 1 in 10,000 to 1 in 30,000 individuals worldwide. Because the condition presents with a wide spectrum of clinical severity, many mild cases likely go undiagnosed, suggesting that the true prevalence may be higher than current clinical estimates indicate.

What is the estimated prevalence and incidence of Cornelia de Lange syndrome?

Determining the exact prevalence of Cornelia de Lange syndrome is challenging due to clinical heterogeneity. Current medical literature, including data from Orphanet, typically cites a prevalence range of 1 in 10,000 to 1 in 30,000. Incidence—the number of new cases diagnosed each year—is difficult to track precisely because many individuals with milder presentations are identified later in childhood or even adulthood. The Cornelia de Lange syndrome community is global, and cases have been reported across all ethnic and geographic populations, with no evidence suggesting that the condition is more prevalent in any specific demographic group.

Are there differences in gender or age distribution?

Cornelia de Lange syndrome is generally considered to affect males and females with equal frequency. While the condition is primarily diagnosed in the pediatric population due to characteristic physical features and developmental delays, it is a lifelong condition. As diagnostic testing, such as multi-gene panel sequencing, becomes more accessible, we are seeing an increase in the identification of adults who may have previously been undiagnosed or misdiagnosed. The clinical presentation of Cornelia de Lange syndrome often evolves as a patient ages, requiring ongoing multidisciplinary care.

Why is accurate prevalence data for Cornelia de Lange syndrome difficult to obtain?

Several factors contribute to the difficulty in establishing exact statistics for Cornelia de Lange syndrome:

• Clinical Spectrum: The condition ranges from classic, severe presentations to milder forms that may not be immediately recognized by clinicians.


• Underdiagnosis: Individuals with mild symptoms may never seek genetic testing, leading to significant under-reporting in epidemiological studies.


• Diagnostic Evolution: Improvements in genetic technology allow us to identify mutations in genes like NIPBL, SMC1A, and SMC3, which were not previously possible to detect, leading to a recent "increase" in diagnosed cases that reflects better detection rather than a true increase in incidence.


• DiseaseMaps Insight: Real-world data provides a vital complement to clinical studies. Currently, 133 people with Cornelia de Lange syndrome have joined the DiseaseMaps.org community, sharing their lived experiences, which helps researchers understand the true reach and impact of the syndrome beyond clinical trial settings.

Is Cornelia de Lange syndrome considered rare or ultra-rare?

Cornelia de Lange syndrome is classified as a rare disease. While it is not considered "ultra-rare" in the same category as conditions affecting only a few hundred people worldwide, it remains a complex, multisystem disorder that requires specialized, expert-led management. Because it is a rare condition, patients and families often face a "diagnostic odyssey," highlighting the importance of registries like those found on DiseaseMaps.org to connect families and provide researchers with accurate data.

Next steps

• Consult with a clinical geneticist to discuss genetic testing options and counseling for your family.


• Connect with the Cornelia de Lange syndrome community at DiseaseMaps.org to share experiences and learn from others living with the condition.


• Contact national support organizations, such as the CdLS Foundation, which provide resources for navigating medical, educational, and social care.


• Maintain a comprehensive medical history to share with specialists, as this is critical for managing the multisystem nature of the syndrome.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always consult with your physician or a qualified healthcare provider regarding any medical condition.

References

• Orphanet: "Cornelia de Lange Syndrome" (ORPHA:199).


• NIH Genetic and Rare Diseases (GARD) Information Center: "Cornelia de Lange Syndrome."


• OMIM (Online Mendelian Inheritance in Man): Entry #122470.


• CdLS Foundation: Clinical resources and patient support data.